Class 1 recall issued for quetiapine oral suspension The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 1 recall notice for all batches of quetiapine oral suspension (Seroquel; Eaststone Limited), after the manufacturer…

#MHRA issues class 1 recall notice for all batches of #quetiapine oral suspension (#Seroquel; #Eaststone)

#drugsafety #medicinessafety #medicinerecall #mentalhealth #NHS #ukhealthcare

Recall issued for ipratropium bromide solution over label mix-up Accord Healthcare has issued a recall for a batch of ipratropium bromide 500 microgram/2ml nebuliser solution over a labelling error.

Recall issued for ipratropium bromide solution over label mix-up

buff.ly/EzBV9FQ

#medicinerecall #medicinesupplynotification #AccordHealthcare #medicines

Fabupharm told to recall oral liquid medicine after council discovers manufacturing issues The Namibian Medicines Regulatory Council (NMRC) has instructed Fabupharm to recall its oral liquid products over manufacturing standard concerns. NMRC registrar Fransina Nambahu says instructions were issued to Fabupharm Namibia to initiate a recall of all oral liquid products and to stop manufacturing the affected liquid line until certain matters were corrected. “A routine inspection of its manufacturing facility was carried out to validate the status of goods manufacturing practices.” Nambahu says the inspection of the oral liquid dosage block observed shortcomings which necessitated various corrective and preventive actions. “The NMRC is committed to carry out its mandate by ensuring access to safe, effective and quality assured medicines to the Namibian people,” she says. The post Fabupharm told to recall oral liquid medicine after council discovers manufacturing issues appeared first on The Namibian.

#Fabupharm #NMRC #MedicineRecall #PatientSafety #QualityAssurance

Fabupharm ordered to recall oral liquid medicines Fabupharm ordered to recall oral liquid medicines NBC Online Wed, 06/04/2025 - 13:36

#Fabupharm #MedicineRecall #HealthNews #Pharmaceuticals #Namibia

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication made there has been tied to deaths of U.S. patients.

Glenmark Pharmaceuticals has recalled two dozen generic medicines sold to American patients because the Indian factory that made them failed to comply with U.S. manufacturing standards, federal records show.

#MedicineRecall #DrugRecall #GlenmarkPharmaceuticals 💊

www.propublica.org/article/glen...